ES2144291T3 - Utilizacion de agentes antagonistas no peptidicos de bradiquinina para el tratamiento y la prevencion de enfermedades hepaticas cronicas-fibrogeneticas, enfermedades hepaticas agudas y complicaciones ligadas a ellas. - Google Patents

Utilizacion de agentes antagonistas no peptidicos de bradiquinina para el tratamiento y la prevencion de enfermedades hepaticas cronicas-fibrogeneticas, enfermedades hepaticas agudas y complicaciones ligadas a ellas.

Info

Publication number
ES2144291T3
ES2144291T3 ES97108096T ES97108096T ES2144291T3 ES 2144291 T3 ES2144291 T3 ES 2144291T3 ES 97108096 T ES97108096 T ES 97108096T ES 97108096 T ES97108096 T ES 97108096T ES 2144291 T3 ES2144291 T3 ES 2144291T3
Authority
ES
Spain
Prior art keywords
hepatic diseases
chronic
treatment
bradiquinine
fibrogenetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97108096T
Other languages
English (en)
Spanish (es)
Inventor
Holger Heitsch
Adalbert Wagner
Klaus Wirth
Max Hropot
Martin Bickel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996120509 external-priority patent/DE19620509A1/de
Priority claimed from DE19632042A external-priority patent/DE19632042A1/de
Priority claimed from DE19639303A external-priority patent/DE19639303A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2144291T3 publication Critical patent/ES2144291T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES97108096T 1996-05-22 1997-05-20 Utilizacion de agentes antagonistas no peptidicos de bradiquinina para el tratamiento y la prevencion de enfermedades hepaticas cronicas-fibrogeneticas, enfermedades hepaticas agudas y complicaciones ligadas a ellas. Expired - Lifetime ES2144291T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE1996120509 DE19620509A1 (de) 1996-05-22 1996-05-22 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19632042A DE19632042A1 (de) 1996-08-08 1996-08-08 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19639303A DE19639303A1 (de) 1996-09-25 1996-09-25 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US08/858,550 US5786365A (en) 1996-05-22 1997-05-19 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Publications (1)

Publication Number Publication Date
ES2144291T3 true ES2144291T3 (es) 2000-06-01

Family

ID=27438369

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97108096T Expired - Lifetime ES2144291T3 (es) 1996-05-22 1997-05-20 Utilizacion de agentes antagonistas no peptidicos de bradiquinina para el tratamiento y la prevencion de enfermedades hepaticas cronicas-fibrogeneticas, enfermedades hepaticas agudas y complicaciones ligadas a ellas.

Country Status (23)

Country Link
US (1) US5786365A (ja)
EP (2) EP0808627A2 (ja)
JP (1) JP4034849B2 (ja)
CN (1) CN1176102A (ja)
AT (1) ATE189389T1 (ja)
AU (1) AU2351197A (ja)
BR (1) BR9703367A (ja)
CA (1) CA2205780A1 (ja)
CZ (1) CZ154697A3 (ja)
DE (1) DE59701078D1 (ja)
DK (1) DK0808628T3 (ja)
ES (1) ES2144291T3 (ja)
GR (1) GR3033048T3 (ja)
HR (1) HRP970278A2 (ja)
HU (1) HUP9700913A1 (ja)
ID (1) ID18447A (ja)
IL (1) IL120862A0 (ja)
NO (1) NO972311L (ja)
PL (1) PL320134A1 (ja)
PT (1) PT808628E (ja)
SI (1) SI0808628T1 (ja)
SK (1) SK63097A3 (ja)
TR (1) TR199700392A2 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19712960A1 (de) 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
WO2000027415A2 (en) 1998-11-10 2000-05-18 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5
AU773862B2 (en) * 1998-11-10 2004-06-10 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
US6767889B1 (en) 1998-11-10 2004-07-27 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
US6869931B1 (en) 1998-12-16 2005-03-22 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
US6994852B1 (en) * 1999-11-12 2006-02-07 Temple University-Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US6445588B1 (en) 2001-01-02 2002-09-03 Motorola, Inc. Apparatus and method for securing a printed circuit board to a base plate
BRPI0417543A (pt) 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
AU2006228957A1 (en) * 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase
US10517765B2 (en) 2010-06-29 2019-12-31 Jennifer DiGrazia Wound and bandage protection system and method
CA2839850A1 (en) * 2010-06-29 2012-01-12 Jennifer Digrazia Wound and bandage protection system and method
RU2514345C1 (ru) * 2012-10-09 2014-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования степени риска геморрагических осложнений при миниинвазивных хирургических вмешательствах на печени

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP3049648B2 (ja) * 1993-12-13 2000-06-05 日立金属株式会社 加圧成形方法および加圧成形機
EP0774462A4 (en) * 1994-08-03 1997-10-29 Fujisawa Pharmaceutical Co HETEROCYCLIC COMPOUND

Also Published As

Publication number Publication date
JPH1045624A (ja) 1998-02-17
NO972311L (no) 1997-11-24
DE59701078D1 (de) 2000-03-09
HRP970278A2 (en) 1998-04-30
GR3033048T3 (en) 2000-08-31
EP0808628A3 (de) 1998-01-14
DK0808628T3 (da) 2000-06-26
HUP9700913A1 (hu) 1999-09-28
ID18447A (id) 1998-04-09
ATE189389T1 (de) 2000-02-15
CZ154697A3 (en) 1997-12-17
IL120862A0 (en) 1997-09-30
NO972311D0 (no) 1997-05-21
EP0808627A2 (de) 1997-11-26
BR9703367A (pt) 1998-09-15
SI0808628T1 (en) 2000-04-30
AU2351197A (en) 1997-11-27
HU9700913D0 (en) 1997-07-28
SK63097A3 (en) 1997-12-10
CN1176102A (zh) 1998-03-18
PL320134A1 (en) 1997-11-24
TR199700392A2 (xx) 1997-12-21
EP0808628A2 (de) 1997-11-26
US5786365A (en) 1998-07-28
CA2205780A1 (en) 1997-11-22
MX9703725A (es) 1997-11-29
PT808628E (pt) 2000-05-31
JP4034849B2 (ja) 2008-01-16
EP0808628B1 (de) 2000-02-02

Similar Documents

Publication Publication Date Title
ES2144291T3 (es) Utilizacion de agentes antagonistas no peptidicos de bradiquinina para el tratamiento y la prevencion de enfermedades hepaticas cronicas-fibrogeneticas, enfermedades hepaticas agudas y complicaciones ligadas a ellas.
FR22C1036I1 (fr) Derives d'une pyrimidine en tant qu'inhibiteur du vih
WO2002047679A3 (en) Nonpeptide agonists and antagonists of vasopressin receptors
DE122008000021I2 (de) Sulfonamidderivate als Wirkstoff-Vorläufer vom Inhibitoren der Aspartyl-Protease
MA27679A1 (fr) Derives d'acides carboxyliques en tant qu'antagonistes ip
ES2178298T3 (es) Compuestos anti-inflamatorios.
DE69935116D1 (de) Pumpzerstäuber vom Triggertyp
MA26994A1 (fr) Quinazolines en tant qu'inhibiteurs de la mmp-13
FR2809315B1 (fr) Pompe pour produits pharmaceutiques avec boucles de suture affleurant a la surface exterieure
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
AR025883A1 (es) Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos
RS50071B (sr) Novi oblik soli pantoprazola
PA8543201A1 (es) DERIVADOS DE DIHIDRO-BENZO [B] [1,4]-DIAZEPIN-2-ONA COMO ANTAGONISTAS I DE mGluR2
MA26958A1 (fr) Derives de 2-phenylaminoimidazoline phenyl cetone substituee en tant qu'antagonistes ip
IT8820127A0 (it) Impiego di derivati dei perfluoropolieteri in forma di microemulsione acquosa per la protezione dei materiali lapidei dagli agenti atmosferici.
ATE283630T1 (de) Fungizide zusammensetzungen auf der basis von pyridylmethylbenzamid-derivate und mindestens einer der komplex iii hemmender verbindung
TR200002542T2 (tr) Meta-azasiklik amino benzoik asit bileşikleri ve bunların integrin antagonistleri olan türevleri
WO2002042303A3 (en) Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
EA200001039A1 (ru) Кальцилитические соединения
FI962073A0 (fi) HIV-proteaasin estäjän prodrug-muotoja
RS51003B (sr) Derivat piridin-1-oksida i postupak za njegovu transformaciju u farmaceutski efikasna jedinjenja
SE9801494D0 (sv) Novel use
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила
ITRM950273A0 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni farmaceutiche.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 808628

Country of ref document: ES